Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Schizophrenia

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Leaving the study early · patients with schizophrenia

It is very uncertain whether chlorpromazine changes leaving the study early ‐ for any reason compared with piperacetazine (very low certainty).

1 finding from 1 review

Chlorpromazine versus piperacetazine for schizophrenia 2018 · Cochrane Headline outcomes only
RR 0.5 [0.1, 2.56]
4 studies · 256 participants
Very low

Leaving the study early · patients with schizophrenia

It is very uncertain whether chlorpromazine changes leaving the study early: for any reason compared with clotiapine (very low certainty).

1 finding from 1 review

Chlorpromazine versus clotiapine for schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.68 [0.24, 1.88]
3 studies · 158 participants
Very low